# Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

> **NCT03154710** · NA · TERMINATED · sponsor: **Weprom** · enrollment: 52 (actual)

## Conditions studied

- Lymphoma, T-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Hodgkin

## Interventions

- **DEVICE:** MOOVCARE

## Key facts

- **NCT ID:** NCT03154710
- **Lead sponsor:** Weprom
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-12
- **Primary completion:** 2020-10-14
- **Final completion:** 2021-03-12
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Negative interim analysis
- **Last updated:** 2021-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03154710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03154710, "Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03154710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*